Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 64

Sort by

Sort Order Select

Journal Articles

Lamictal® and Hemophagocytic Lymphohistiocytosis (HLH)

Ibrahim Tora, MD, Logan Rhea, DO, Margaret Holbrook, Physician Assistant, William Ershler, MD, Yemsrach Gami, MD

Blood (2019) 134 (Supplement_1): 4880.

https://doi.org/10.1182/blood-2019-127531

Published: 2019

Journal Articles

Characterization and treatment of congenital thrombotic thrombocytopenic purpura

Blood (2019) 133 (15): 1644–1651.

https://doi.org/10.1182/blood-2018-11-884700

Published: 2019

Journal Articles

A Phase 1 Study Investigating AFM11 in Patients with Relapsed/Refractory B Cell Precursor Acute Lymphoblastic Leukemia: Preliminary Results

Galina Salogub, MD PhD, Jiri Mayer, MD, Frantisek Folber, MD PhD, Sebastian Grosicki, MD PhD, Aleksander B Skotnicki, MD PhD, Anna Prochwicz, MD, Alexander Myasnikov, MD, Alexander Gural, MD, Oliver Schoenborn-Kellenberger, MSc, Charlie Brindley, PhD, Stefan Knackmuss, PhD, Sylvia Schwarz, PhD, Sandra Schmich, Cassandra Choe-Juliak, MD MS, Andras Strassz, MD, Leila Alland, MD, Michael Doubek, MD PhD

Blood (2018) 132 (Supplement 1): 3969.

https://doi.org/10.1182/blood-2018-99-118136

Published: 2018

Journal Articles

Transcriptomic Systems Biology Analyses with Buparlisib (BKM120) Pan PI3K Inhibition in Canine B Cell Lymphoma (BCL): Leveraging Comparative Oncology for Cancer Therapeutics and Biomarker Discovery

Ravi Dashnamoorthy, PhD, Afshin Beheshti, PhD, Sarah Cass, BSVM, Athena Kritharis, MD, Kristine Burgess, DVM, MS, Cheryl London, DVM, PhD DACVIM, Andrew M. Evens, DO, MSc

Blood (2018) 132 (Supplement 1): 4114.

https://doi.org/10.1182/blood-2018-99-118548

Published: 2018

Journal Articles

A New Flow-Based Assay to Assess Treatment Response in Congenital Thrombotic Thrombocytopenic Purpura

Ferras Alwan, Chiara Vendramin, Alice Taylor, Mari Thomas, PhD, Ri Liesner, Marie Scully, MD MRCP, FRCPath

Blood (2018) 132 (Supplement 1): 2441.

https://doi.org/10.1182/blood-2018-99-115965

Published: 2018

Journal Articles

JCARH125, Anti-BCMA CAR T-cell Therapy for Relapsed/Refractory Multiple Myeloma: Initial Proof of Concept Results from a Phase 1/2 Multicenter Study (EVOLVE)

Sham Mailankody, MBBS, Myo Htut, MD, Kelvin P. Lee, MD, William Bensinger, MD, Todd Devries, PhD, Julia Piasecki, BA, Safiyyah Ziyad, PhD, Michelle Blake, PhD, John Byon, MDPhD, Andrzej Jakubowiak, MD PhD

Blood (2018) 132 (Supplement 1): 957.

https://doi.org/10.1182/blood-2018-99-113548

Published: 2018

Journal Articles

Hypercalcemia- Leukocytosis Syndrome: A Rare Ominous Indicator in Lung Cancer

Taylor Hanson, Ravi Patel, DO, Nitasa Sahu, MD, Zain Ayaz, MD, Julie Caler, Pharm.D, Kirk Jones, Pharm.D, Rohit Jain, MBBS

Blood (2018) 132 (Supplement 1): 4966.

https://doi.org/10.1182/blood-2018-99-112705

Published: 2018

Journal Articles

Phase I/II Study of Escalating Doses of Thalidomide in Conjunction with Bortezomib and High Dose Melphalan As a Conditioning Regimen for Autologous Stem Cell Transplantation in Patients with Multiple Myeloma

Noa Biran, MD, Shijia Zhang, MD PhD, Scott D. Rowley, MD, David H. Vesole, MD PhD, Michele L. Donato, MD, Alan P Skarbnik, MD, Joshua R Richter, MD, Andrew L. Pecora, MD, David S Siegel, MD PhD

Blood (2018) 132 (Supplement 1): 2154.

https://doi.org/10.1182/blood-2018-99-114832

Published: 2018

Journal Articles

Establishment of Human Acute Monocyte Leukemia Model with Systemic Leukemia in Npg Mice

Jing Xu, Zhenjiang Li, Qiong Wu, Wenfeng He, Jifu Zheng, Qingming Wang, Aiping Tang, Wanlei Sun, Yanfei Rao

Blood (2018) 132 (Supplement 1): 4041.

https://doi.org/10.1182/blood-2018-99-112395

Published: 2018

Journal Articles

The Long-Term Adverse Event Profile of Oral Eliglustat for the Treatment of Gaucher Disease Type 1: Pooled Analysis of Data from 393 Patients in 4 Completed Trials

M. Judith Peterschmitt, MD, Selena Freisens, MD, Audrey W Hou, PharmD, Lisa Underhill, MS, Meredith C. Foster, ScD, Sebastiaan J.M. Gaemers, MD

Blood (2018) 132 (Supplement 1): 3692.

https://doi.org/10.1182/blood-2018-99-118319

Published: 2018

Journal Articles

Use of Hemoglobin Based Oxygen Carrier HBOC-021 (Hemopure) As a Bridge during Emergencies in Patients Unable to Receive Blood Products: Experience at a Tertiary Care Center

Shahla Bari, MD, Marina Rabinovich, PharmD, BCPS, Marjorie Curry, PharmD, BCOP, Sanjay Raj Jain, MD PhD, Lorraine Cafuir, MD

Blood (2017) 130 (Supplement 1): 4926.

https://doi.org/10.1182/blood.V130.Suppl_1.4926.4926

Published: 2017

Journal Articles

Eltrombopag (EPAG) Treatment Improved Platelet Counts in Patients with Persistent or Chronic Immune Thrombocytopenia during a 2-Year, Phase IV, Open-Label Study

Raymond SM Wong, MRCP,FRCP, Russell K Brynes, Attilio Orazi, Zeba Aziz, MD MBBS, Anait L. Melikyan, MD PhD, Abdulgabar Salama, Ozlem Ocak Arikan, Joan Maier, Tahir Shamsi, Professor of Haematology (FRCPath)

Blood (2017) 130 (Supplement 1): 3628.

https://doi.org/10.1182/blood.V130.Suppl_1.3628.3628

Published: 2017

Journal Articles

Characterizing the United Kingdom Congenital Thrombotic Thrombocytopenic Purpura Population

Ferras Alwan, MBBS, Chiara Vendramin, Ri Liesner, Tina Dutt, Amanda Clark, Jayashree Motwani, Will Lester, Vickie McDonald, Rachel Rayment, Nichola Cooper, MA, MD MRCP, FRCPath, Richard Gooding, Hamish Lyall, Tina Biss, MD, Joost van Veen, Henry G Watson, John-Paul Westwood, Mari Thomas, Marie Scully

Blood (2017) 130 (Supplement 1): 3616.

https://doi.org/10.1182/blood.V130.Suppl_1.3616.3616

Published: 2017

Journal Articles

A Rare Case of Hemophagocytic Lymphohistiocytosis of Unknown Etiology

Ida Micaily, MD, Marie-Helene Gagnon, MD, Richard Friedenheim, MD, Jason A. Damsker, MD

Blood (2017) 130 (Supplement 1): 4831.

https://doi.org/10.1182/blood.V130.Suppl_1.4831.4831

Published: 2017

Journal Articles

Possible Therapeutic Potential of Recombinant Human Soluble Thrombomoduline Alpha for the Treatment of SOS/VOD: A Retrospective Study in Toranomon Hospital

Shinsuke Takagi, MD PhD, Mitsuhiro Yuasa, MD, Naoyuki Uchida, MD PhD, Kyosuke Yamaguchi, MD, Kosei Kageyama, MD, Daisuke Kaji, MD, Yuki Taya, MD PhD, Aya Nishida, MD, Kazuya Ishiwata, MD, Hisashi Yamamoto, MD, Go Yamamoto, MD PhD, Yuki Asano-Mori, MD PhD, Atsushi Wake, MD PhD, Shigeyoshi Makino, MD PhD, Akiko Yoneyama, MD PhD, Koji Izutsu, MD PhD, Shuichi Taniguchi, MD PhD

Blood (2016) 128 (22): 5747.

https://doi.org/10.1182/blood.V128.22.5747.5747

Published: 2016

Journal Articles

Phase 1 Study of the Novel Kinesin Spindle Protein Inhibitor Filanesib + Carfilzomib in Patients with Relapsed and/or Refractory Multiple Myeloma (RRMM)

Jatin J. Shah, MD, Lei Feng, MS, Sheeba K. Thomas, MD, Donna Weber, MD, Michael Wang, MD, Elisabet E. Manasanch, MD, Kathleen Mendoza, RN, Robert Z. Orlowski, PhD, MD

Blood (2015) 126 (23): 376.

https://doi.org/10.1182/blood.V126.23.376.376

Published: 2015

Journal Articles

A Qualitative Research Study to Understand Post-Transfusion Well-Being in Patients with Myelodysplastic Syndromes

Naushin S. Sholapur, BHSc, MSc (C), Shannon Lane, Christopher M Hillis, MD FRCPC, Mark A. Crowther, MD MSc, FRCPC, Brian Leber, MD, Richard Cook, M. Math, PhD, Ronald Barr, MD, Nancy M. Heddle, MSc, FCSMLS(D)

Blood (2015) 126 (23): 4446.

https://doi.org/10.1182/blood.V126.23.4446.4446

Published: 2015

Journal Articles

Improved Patient-Derived Xenograft Model for Acute Myeloid Leukemia

Xiaochuan Shan, MDPhD, Cedric Dos Santos, PhD, Chenghui Zhou, Georges Habineza Ndikuyeze, Anthony Secreto, Joshua Glover, Winifred Trotman, MS, Martin Carroll, MD, Gwenn Danet-Desnoyers, PhD

Blood (2014) 124 (21): 3491.

https://doi.org/10.1182/blood.V124.21.3491.3491

Published: 2014

Journal Articles

No Survival Improvement for Central Nervous System Multiple Myeloma By the Use of Novel Anti-Myeloma Agents: The Greek Myeloma Study Group Experience

Blood (2014) 124 (21): 4752.

https://doi.org/10.1182/blood.V124.21.4752.4752

Published: 2014

Journal Articles

Expanded Therapeutic Index Of Antithrombin Silencing and Correction Of Aptt In a Hemophilia A Mouse Model

Scott A Barros, PhD, DABT, Mary Carioto, Julia Hettinger, Yongfeng Jiang, June Qin, Harsha Prabhala, Alfica Sehgal, PhD, Akin Akinc, PhD

Blood (2013) 122 (21): 3585.

https://doi.org/10.1182/blood.V122.21.3585.3585

Published: 2013

NARROW

Lamictal® and Hemophagocytic Lymphohistiocytosis (HLH)

Characterization and treatment of congenital thrombotic thrombocytopenic purpura

A Phase 1 Study Investigating AFM11 in Patients with Relapsed/Refractory B Cell Precursor Acute Lymphoblastic Leukemia: Preliminary Results

Transcriptomic Systems Biology Analyses with Buparlisib (BKM120) Pan PI3K Inhibition in Canine B Cell Lymphoma (BCL): Leveraging Comparative Oncology for Cancer Therapeutics and Biomarker Discovery

A New Flow-Based Assay to Assess Treatment Response in Congenital Thrombotic Thrombocytopenic Purpura

JCARH125, Anti-BCMA CAR T-cell Therapy for Relapsed/Refractory Multiple Myeloma: Initial Proof of Concept Results from a Phase 1/2 Multicenter Study (EVOLVE)

Hypercalcemia- Leukocytosis Syndrome: A Rare Ominous Indicator in Lung Cancer

Phase I/II Study of Escalating Doses of Thalidomide in Conjunction with Bortezomib and High Dose Melphalan As a Conditioning Regimen for Autologous Stem Cell Transplantation in Patients with Multiple Myeloma

Establishment of Human Acute Monocyte Leukemia Model with Systemic Leukemia in Npg Mice

The Long-Term Adverse Event Profile of Oral Eliglustat for the Treatment of Gaucher Disease Type 1: Pooled Analysis of Data from 393 Patients in 4 Completed Trials

Use of Hemoglobin Based Oxygen Carrier HBOC-021 (Hemopure) As a Bridge during Emergencies in Patients Unable to Receive Blood Products: Experience at a Tertiary Care Center

Eltrombopag (EPAG) Treatment Improved Platelet Counts in Patients with Persistent or Chronic Immune Thrombocytopenia during a 2-Year, Phase IV, Open-Label Study

Characterizing the United Kingdom Congenital Thrombotic Thrombocytopenic Purpura Population

A Rare Case of Hemophagocytic Lymphohistiocytosis of Unknown Etiology

Possible Therapeutic Potential of Recombinant Human Soluble Thrombomoduline Alpha for the Treatment of SOS/VOD: A Retrospective Study in Toranomon Hospital

Phase 1 Study of the Novel Kinesin Spindle Protein Inhibitor Filanesib + Carfilzomib in Patients with Relapsed and/or Refractory Multiple Myeloma (RRMM)

A Qualitative Research Study to Understand Post-Transfusion Well-Being in Patients with Myelodysplastic Syndromes

Improved Patient-Derived Xenograft Model for Acute Myeloid Leukemia

No Survival Improvement for Central Nervous System Multiple Myeloma By the Use of Novel Anti-Myeloma Agents: The Greek Myeloma Study Group Experience

Expanded Therapeutic Index Of Antithrombin Silencing and Correction Of Aptt In a Hemophilia A Mouse Model

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only